Preview: Apogee Therapeutics, Inc Set To IPO Tomorrow

Apogee Therapeutics, Inc APGE IPO will take place July, 14 on the NASDAQ exchange under the ticker APGE.

The company is offering shares at an expected price between $15.00 and $17.00 per share with an insider lock-up period of 180 days ending on January 10, 2024.

See also: Benzinga IPO Calendar

About Apogee Therapeutics, Inc

Apogee Therapeutics, Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of AD, COPD, and related I&I indications with high unmet need.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.